• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

Baxter International's Prognosis Looks Poor, Consider Selling

BAX saw shares plunge 10% last week on news of accounting irregularities and the charts appear bearish.
By BRUCE KAMICH
Oct 30, 2019 | 11:48 AM EDT
Stocks quotes in this article: BAX

Shares of Baxter International Inc. (BAX)  plunged 10% last week after the company announced it is opening an investigation into accounting irregularities. Are shares are a buy, or should investors jump ship?

Jim Cramer on his "Mad Money" show said his hard-and-fast rule is that accounting issues always mean sell, but if anyone deserves the benefit of the doubt, it's the tried-and-true folks at Baxter. According to the announcement, the issue stems from how the company accounted for foreign exchange rates internally. The discrepancy, if true, could be worth seven cents a share to Baxter's earnings. With shares already off 10%, Cramer said the worst case is already baked into the share price.

But even with Baxter's earnings momentum, Cramer said he has to stick with his rule and sell. No amount of good news can offset the fear that accounting issues can cause, he said, so until Baxter sounds the all-clear, investors need to stay away. Let's check in with the charts and indicators to see if there is more risk ahead.

In this daily bar chart of BAX, below, we can see that prices and the indicators are all aligned to the downside. Prices have continued to weaken after the big bearish gap to the downside and that is a sign that the lower price is still not attractive enough for investors.

The shorter 50-day moving average line has turned down and it's negative slope is bearish. The slower-to-react 200-day moving average line is cresting and the price of BAX is below both averages. The On-Balance-Volume (OBV) line is pointed down telling us that sellers are more aggressive and the Moving Average Convergence Divergence (MACD) oscillator is bearish.

In this weekly bar chart of BAX, below, the gap disappears, but the chart is still bearish with the price of BAX below the cresting 40-week moving average line. Trading volume increased in the direction of the trend which is now down. The weekly OBV line has started to turn lower and the MACD oscillator has crossed to the downside for a take-profits sell signal.

In this Point and Figure chart of BAX, below, we can see that the software has counted the distribution pattern and has generated a potential downside price target of $63.

Bottom line strategy: With all three charts (above) of BAX bearish, and with a potential $63 price target, I see no reason to be long on BAX. Time to jump ship if you have not already done so.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Healthcare | Pharmaceuticals | Technology | Mad Money

More from Investing

It's Big-Cap AI Stocks Vs. Everything Else

James "Rev Shark" DePorre
May 30, 2023 4:35 PM EDT

The biggest problem now is that the big-cap names are not acting as leaders.

Beyond Meat and Peloton: Zombie Stocks Can Turn Portfolios Into the Walking Dead

Brad Ginesin
May 30, 2023 3:30 PM EDT

Don't confuse a stock revival masquerading as a living, breathing business revival.

In Case You Missed It: Apple Just Hit a New 52-Week High

Bruce Kamich
May 30, 2023 2:45 PM EDT

Let's not ignore the strength in AAPL.

Where Can Investors Slip Into Shares of Skechers?

Bruce Kamich
May 30, 2023 2:29 PM EDT

The charts show where SKX's prices would be the perfect fit.

How Many Forward Gears Does Ferrari Stock Have?

Bruce Kamich
May 30, 2023 1:51 PM EDT

Let's check under the hood.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:48 AM EDT CHRIS VERSACE

    Latest AAP Podcast With Portillo's CEO!

    Listen in as we talk with a rising star in the Chi...
  • 03:25 PM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Don't Just Sit There and 'Hope' for Your Stocks, M...
  • 07:32 AM EDT BOB LANG

    Webinar Thursday After the Close: Option Spread Trading

    Thursday, my good friend and colleague Sam DeMarco...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login